uracil has been researched along with Acquired Immune Deficiency Syndrome in 5 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| "AIDS Clinical Trials Group study A5334s evaluated the pharmacokinetics of raltegravir before and during combined administration of ombitasvir, paritaprevir/ritonavir, plus dasabuvir (OBV/PTV/r + DSV) and weight-based ribavirin in human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfected adults." | 9.34 | Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s. ( Alston-Smith, BL; Cohen, DE; Cramer, YS; Morse, GD; Rosenkranz, SL; Schmidt, J; Sulkowski, M; Venuto, CS; Wyles, DL, 2020) |
| "AIDS Clinical Trials Group study A5334s evaluated the pharmacokinetics of raltegravir before and during combined administration of ombitasvir, paritaprevir/ritonavir, plus dasabuvir (OBV/PTV/r + DSV) and weight-based ribavirin in human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfected adults." | 5.34 | Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s. ( Alston-Smith, BL; Cohen, DE; Cramer, YS; Morse, GD; Rosenkranz, SL; Schmidt, J; Sulkowski, M; Venuto, CS; Wyles, DL, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Venuto, CS | 2 |
| Cramer, YS | 1 |
| Rosenkranz, SL | 1 |
| Sulkowski, M | 1 |
| Wyles, DL | 2 |
| Cohen, DE | 2 |
| Schmidt, J | 1 |
| Alston-Smith, BL | 1 |
| Morse, GD | 2 |
| Balagopal, A | 1 |
| Smeaton, LM | 1 |
| Quinn, J | 1 |
| Vu, V | 1 |
| Alston-Smith, B | 1 |
| Santana-Bagur, JL | 1 |
| Anthony, DD | 1 |
| Sulkowski, MS | 1 |
| Talal, AH | 1 |
| Baba, M | 1 |
| Shigeta, S | 1 |
| Tanaka, H | 1 |
| Miyasaka, T | 1 |
| Ubasawa, M | 1 |
| Umezu, K | 1 |
| Walker, RT | 1 |
| Pauwels, R | 1 |
| De Clercq, E | 1 |
| Araujo, FG | 1 |
| Huskinson, J | 1 |
| Remington, JS | 1 |
| Falcone, A | 1 |
| Darnowski, JW | 1 |
| Ruprecht, RM | 1 |
| Chu, SH | 1 |
| Brunetti, I | 1 |
| Calabresi, P | 1 |
1 review available for uracil and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivatives.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4-Positive T-Lymphocytes; Drug Combinations; | 1992 |
2 trials available for uracil and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s.
Topics: 2-Naphthylamine; Acquired Immunodeficiency Syndrome; Adult; Anilides; Antiviral Agents; Coinfection; | 2020 |
Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy.
Topics: 2-Naphthylamine; Acquired Immunodeficiency Syndrome; Adult; Anilides; Antiviral Agents; Carbamates; | 2020 |
2 other studies available for uracil and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Infective Agents; Atovaquone; Brain; Cell Division | 1991 |
Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Dose-Response Relationship, Drug; Female; Kinet | 1990 |